論文

査読有り
2020年5月

Hexapeptide derived from prothymosin alpha attenuates cisplatin-induced acute kidney injury.

Clinical and experimental nephrology
  • Kenta Torigoe
  • ,
  • Yoko Obata
  • ,
  • Miki Torigoe
  • ,
  • Satoru Oka
  • ,
  • Kazuo Yamamoto
  • ,
  • Takehiko Koji
  • ,
  • Hiroshi Ueda
  • ,
  • Hiroshi Mukae
  • ,
  • Tomoya Nishino

24
5
開始ページ
411
終了ページ
419
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1007/s10157-019-01843-1

BACKGROUND: Prothymosin alpha (ProTα) is a nuclear protein expressed in virtually all mammalian tissues. Previous studies have shown that ProTα exhibits protective effects against ischemia-induced cell death in various cell types. Recently, the 6-residue peptide P6Q (NEVDQE), the modified form of the active 6-residue core (51-56) in ProTα, has also been shown to have protective effects against retinal ischemia. However, it remains to be elucidated whether P6Q is effective against acute kidney injury (AKI). Therefore, we investigated the renoprotective effect of P6Q on cisplatin-induced AKI. METHODS: Cultured HK-2 cells were treated with cisplatin for 24 h and pretreatment with ProTα or P6Q was carried out 30 min before cisplatin treatment. Cell viability was evaluated using the MTT assay. In an in vivo study, 8-week-old male Wistar rats were divided into control, cisplatin treated, and cisplatin treated with P6Q injection groups. In the last of these, P6Q was injected intravenously before cisplatin treatment. Then, we evaluated the renoprotective effect of P6Q. RESULTS: In the study on cultured cells, pretreatment with ProTα or P6Q prevented cisplatin-induced cell death. In the in vivo study, pretreatment with P6Q significantly attenuated cisplatin-induced increase in serum creatinine and blood urea nitrogen levels, renal tubular cell injury, and apoptosis. Moreover, P6Q attenuated the mitochondrial apoptotic pathway and accelerated Akt phosphorylation after cisplatin-induced renal damage. CONCLUSION: Taken together, our findings indicate that P6Q can attenuate cisplatin-induced AKI and suppress the mitochondrial apoptotic pathway via Akt phosphorylation. These data suggest that P6Q has potential as a preventative drug for cisplatin-induced AKI.

リンク情報
DOI
https://doi.org/10.1007/s10157-019-01843-1
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/31912273

エクスポート
BibTeX RIS